0001493152-24-033277.txt : 20240820
0001493152-24-033277.hdr.sgml : 20240820
20240820163517
ACCESSION NUMBER: 0001493152-24-033277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240815
FILED AS OF DATE: 20240820
DATE AS OF CHANGE: 20240820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Gregory
CENTRAL INDEX KEY: 0001329505
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 241225679
MAIL ADDRESS:
STREET 1: 4 A CHESHAM STREET
CITY: LONDON
STATE: X0
ZIP: SW1X8DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Serina Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821436829
STATE OF INCORPORATION: AL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
BUSINESS PHONE: (256) 327-9630
MAIL ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
FORMER COMPANY:
FORMER CONFORMED NAME: AgeX Therapeutics, Inc.
DATE OF NAME CHANGE: 20170606
4
1
ownership.xml
X0508
4
2024-08-15
0
0001708599
Serina Therapeutics, Inc.
SER
0001329505
Bailey Gregory
601 GENOME WAY, SUITE 2001
HUNTSVILLE
AL
35806
1
0
0
0
0
Common Stock
2024-08-15
4
P
0
6400
6.6526
A
33006
D
Common Stock
2024-08-16
4
P
0
6400
7.3093
A
39406
D
Common Stock
2024-08-19
4
P
0
6400
7.9313
A
45806
D
The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.55 per share to a high of $7.94 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.12 per share to a high of $8.02 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.24 per share to a high of $8.57 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
/s/ Gregory Bailey
2024-08-20